Dr. Micallef is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of British ColumbiaClass of 1990
Certifications & Licensure
MN State Medical License 2000 - 2025
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma Start of enrollment: 2004 Dec 01
- Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma Start of enrollment: 2006 Jan 01
- Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2004 Oct 01
Publications & Presentations
PubMed
- 65 citationsPatients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myelom...Angela Dispenzieri, K Seenithamby, Martha Q. Lacy, Shaji Kumar, Francis K. Buadi
Bone Marrow Transplantation. 2013-10-01 - 616 citationsPlerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaJohn F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Ivana N. Micallef, Patrick J. Stiff
Blood. 2009-06-04 - 521 citationsPhase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte ...John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz
Journal of Clinical Oncology. 2009-10-01
Abstracts/Posters
- Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution ExperienceIvana Micallef, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell LymphomaIvana Micallef, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
